Page last updated: 2024-10-26

dimaprit and Diabetes, Gestational

dimaprit has been researched along with Diabetes, Gestational in 1 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Diabetes, Gestational: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.

Research Excerpts

ExcerptRelevanceReference
"Women with gestational diabetes (GDM) have an increased risk of preeclampsia and postpartum diabetes."1.72Mediators of inflammation resolution and vasoactive eicosanoids in gestational diabetes and preeclampsia. ( Barden, AE; Beilin, LJ; Mori, TA; Phillips, M; Shinde, S, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Barden, AE1
Shinde, S1
Phillips, M1
Beilin, LJ1
Mori, TA1

Other Studies

1 other study available for dimaprit and Diabetes, Gestational

ArticleYear
Mediators of inflammation resolution and vasoactive eicosanoids in gestational diabetes and preeclampsia.
    Journal of hypertension, 2022, 11-01, Volume: 40, Issue:11

    Topics: Diabetes, Gestational; Dimaprit; Eicosanoids; Female; Glucose; Humans; Inflammation; Inflammation Me

2022